Sangamo Therapeutics, Inc.
METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE I
Last updated:
Abstract:
Described herein are methods and compositions for treating MPS I (Hurler) disease.
Status:
Application
Type:
Utility
Filling date:
7 Aug 2019
Issue date:
6 Aug 2020